1. Home
  2. HE vs NBTX Comparison

HE vs NBTX Comparison

Compare HE & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawaiian Electric Industries Inc.

HE

Hawaiian Electric Industries Inc.

HOLD

Current Price

$11.77

Market Cap

2.3B

Sector

Utilities

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$38.05

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HE
NBTX
Founded
1891
2003
Country
United States
France
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
HE
NBTX
Price
$11.77
$38.05
Analyst Decision
Sell
Strong Buy
Analyst Count
2
1
Target Price
$13.25
$36.00
AVG Volume (30 Days)
1.8M
119.2K
Earning Date
05-08-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
106.32
N/A
EPS
0.89
N/A
Revenue
$3,086,896,000.00
N/A
Revenue This Year
$7.00
$58.17
Revenue Next Year
$4.06
N/A
P/E Ratio
$13.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.79
$8.03
52 Week High
$17.33
$57.14

Technical Indicators

Market Signals
Indicator
HE
NBTX
Relative Strength Index (RSI) 28.72 49.41
Support Level $11.03 $34.83
Resistance Level $11.84 $41.99
Average True Range (ATR) 0.31 1.99
MACD -0.11 -0.09
Stochastic Oscillator 25.27 51.22

Price Performance

Historical Comparison
HE
NBTX

About HE Hawaiian Electric Industries Inc.

Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: